• $102.00
    Market Cap
  • 0.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 40
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.000001
$0.000001
$0.000001
1-Year Range
$0.000001
$0.000001
$0.000001
Latest Close$0.000001
Change
$0.00 (0.00%)
Volume200,000
Market Cap$102.00
Shares Outstanding102.4M
P/E (TTM)-0.000003
Diluted EPS (TTM)-$0.31
Enterprise Value$72.0M

Information as of 05/28/2026

Company Profile

$102.00
Market Cap
-$31.1M
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
2727 North 3rd Street, Phoenix, AZ, United States, 85004
833 867 6337

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It operates through Cultivation, Franchising, and Corporate segments. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.

Key Executives

  • Jeffrey I. Rassas
  • Jayne Levy
  • Mark Busch
  • Cory Carter
  • Kyle Jennings

Current Ownership Distribution

  • Other665.6M (94.84%)
  • Insiders36.2M (5.16%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)